Acute Pancreatitis Clinical Trials

Find Acute Pancreatitis Clinical Trials Near You

Strategic Timing of Endoscopic Procedural Interventions in Infected Necrotizing Pancreatitis: The STEP-IN Trial

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Pancreatic necrosis complicates approximately 20-30% of severe acute pancreatitis cases. While many collections resolve without intervention, persistent symptomatic collections-particularly when infected-are associated with significant morbidity and mortality and frequently require procedural management. Current guidelines recommend delaying intervention until collections are fully walled off, typically around four weeks. However, in clinical practice, many patients deteriorate before this window is reached. Prospective data from our institution, supported by recent meta-analyses, suggest that early intervention using modern endoscopic techniques can be performed safely, even when undertaken within the first four weeks of disease onset. We believe that, in appropriately selected patients, early endoscopic intervention may prevent clinical deterioration, reduce complications, shorten hospital stay, and decrease overall healthcare utilization compared with a delayed approach. To formally evaluate this strategy, an international, multicenter randomized trial is being conducted, entitled Strategic Timing of Endoscopic Procedural Interventions in Infected Necrotizing Pancreatitis (STEP-IN Trial).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years

• Patients with symptomatic necrotic collection diagnosed on MRI or CT abdomen/pelvis, defined as fluid collection in the setting of documented pancreatic necrosis that contains necrotic material and encased within a partial or complete wall.

• Documented or suspected infected necrotizing pancreatitis 1) Documented infected necrotizing pancreatitis, defined as: i. Positive culture obtained with percutaneous fine needle aspiration from the pancreatic necrotic collection (if intervention is undertaken ≤14 days of onset of acute pancreatitis) ii. OR gas in the necrotic collection on imaging at any time. 2) Suspected infected necrotizing pancreatitis, if \>14 days after onset of disease, defined as: i. Persistent organ failure in patients admitted to the ICU ii. OR presence of at least three of the following six clinical/laboratory parameters (SIRS criteria or elevated CRP or elevated procalcitonin) with no other infection focus. These clinical criteria are considered sufficiently reliable only after the initial 14 days of acute pancreatitis:

‣ Temperature \>100.4 °F or \<96.8 °F

⁃ Heart rate \> 90 beats/min

⁃ Respiratory rate \>20 breaths/min or PaCO2 \< 32 mmHg

⁃ WBC count \>12,000/mm³, or \<4,000/mm³, or more than 10% immature band cells

⁃ CRP ≥ 30mg/L

⁃ Procalcitonin ≥ 1ng/mL

• Endoscopic drainage of the necrotic collection is technically feasible as deemed by the treating physician.

Locations
United States
Florida
Orlando Health Digestive Health Institute
RECRUITING
Orlando
Contact Information
Primary
Ji Young Bang, MD MPH
jiyoung.bang@orlandohealth.com
321-842-2273
Backup
Barbara J Broome
Barbara.Broome@orlandohealth.com
321-841-3742
Time Frame
Start Date: 2026-01-28
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 104
Treatments
Active_comparator: Early endoscopic intervention in infected necrotizing pancreatitis
In the early treatment group, EUS-guided drainage is undertaken within 72 hours of randomization, earlier than 28 days after the onset of acute pancreatitis.
Active_comparator: Postponed endoscopic intervention in infected necrotizing pancreatitis
In the postponed treatment group, EUS-guided drainage is undertaken only from 28 days after the onset of acute pancreatitis when the collection is fully or predominantly walled-off (encapsulated).
Sponsors
Leads: Orlando Health, Inc.

This content was sourced from clinicaltrials.gov